Literature DB >> 24126253

Short-term and long-term outcomes of serial robotic training for improving upper limb function in chronic stroke.

Patrizio Sale1, Federica Bovolenta, Maurizio Agosti, Pierina Clerici, Marco Franceschini.   

Abstract

The aim of this study was to determine short-term and long-term changes in motor function in patients with chronic hemiparesis who underwent robot training and to evaluate its long-term benefit after 6 months. This was a longitudinal study with a 6-month follow-up. The 15 patients included in this study underwent the Fugl-Meyer test, the Ashworth Scale test, the Frenchay Arm test, and the Box and Block test according to the following schedule: immediately before (T1, T3) and after each treatment (T2, T4), and 6 months after T4 (T5). There were statistically significant improvements in Fugl-Meyer test between T1 and T2 and between T1 and T4; the score increased in the Ashworth Scale test for Shoulder between T1 and T3 and between T1 and T5; a statistically significant decrease was found between T1 and T2 and between T1 and T4, in the Box and Block test between T1 and T4, and also between T1 and T5. This original rehabilitation treatment may contribute toward increasing upper limb motor recovery in stable chronic stroke patients.

Entities:  

Mesh:

Year:  2014        PMID: 24126253     DOI: 10.1097/MRR.0000000000000036

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  2 in total

1.  Task-oriented robot-assisted stroke therapy of paretic limb improves control in a unilateral and bilateral functional drink task: a case study.

Authors:  Seethu M Christopher; Michelle J Johnson
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2014

2.  Action observation therapy in the subacute phase promotes dexterity recovery in right-hemisphere stroke patients.

Authors:  Patrizio Sale; Maria Gabriella Ceravolo; Marco Franceschini
Journal:  Biomed Res Int       Date:  2014-05-22       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.